NuVasive Inc.

NuVasive Inc.

NuVasive Inc.

Overview
Date Founded

1997

Headquarters

7475 Lusk Boulevard,San Diego, CA 92121-9604

Type of Company

Public

Employees (Worldwide)

2,600

Industries

Medical Products & Equipment
Hospitals & Patient Services
Biotechnology

Company Description

NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA.

Contact Data
Trying to get in touch with decision makers at NuVasive Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

President

Executive Vice President & Chief Financial Officer

Senior Vice President, General Counsel & Corporate Secretary

Chief Compliance Officer

Chief Human Resources Officer

Chairman

Head, Clinical Professional Development

President, US Commercial

Senior Director

Board of Directors

Chief Executive Officer at Corza Health, Inc.

Chairman & Chief Executive Officer at PerkinElmer, Inc.

Executive Vice President, General Counsel & Corporate Secretary at Qualcomm, Inc.

Former Chief Executive Officer at Colubrismx, Inc.

Professional at SenoRx, Inc.

Chairman, President & Chief Executive Officer at Verb Surgical, Inc.

Principal at Norwalk and Associates

Chief Technology Officer & Executive Vice President at Becton, Dickinson & Co.

Chief Executive Officer at NuVasive Inc.

Special Advisor at Manchesterstory Group LLC

Paths to NuVasive Inc.
Potential Connections via
Relationship Science
You
NuVasive Inc.
Owners & Shareholders
Details Hidden

CIP believes that investing in companies with sustainable competitive advantages, durable business models, sound balance sheets, capable and sincere management, and that are trading at valuations that each team deems reasonable can, over time, provide attractive returns with less risk than the overall market. In all of their strategies they actively attempt to minimize business and valuation risk through our well-defined and consistent investment processes. Their investment processes are focused on absolute returns and avoiding large losses, which we believe is critical to wealth creation. Their strategies include small cap equity, mid cap equity, emerging markets equity and emerging markets small cap equity. For CIP's small and mid cap equity, they follow a three-step process: (1) screen all potential companies through unique sector factors; (2) analysis of company fundamentals; (3) valuation analysis. For their emerging markets and emerging markets small cap equity, they also have a process they follow: (1) screen using filters including minimum market cap and liquidity; (2) apply their sector factors - a set of qualitative judgments that target the business models CIP find most attractive; (3) fundamental analysis of company attributes; (4) valuation analysis.

Details Hidden

Consonance Capital Management's (CCM) funds seek to deliver exceptional, uncorrelated risk adjusted returns. CCM seeks to meet this objective by focusing on investment opportunities in the publicly traded stocks of healthcare companies. The firm invests in all sub-sectors of the healthcare sector including healthcare information technology, managed care, pharmaceuticals, specialty pharmaceuticals, commercial stage biotechnology, healthcare facilities and services, medical devices and supplies, diagnostics and consumer-based healthcare companies.CCM believes the public healthcare market lends itself to an active long/short strategy. The firm focuses on creating long and short portfolios driven by the opportunity for absolute return and alpha creation. The funds also invest in other types of securities and may use a variety of investment techniques to generate profit and/or control risk. These may include participating in swaps, buying or selling futures contracts, purchasing and writing options and other derivative contracts, purchasing or selling debt instruments, and trading on margin by borrowing funds and pledging securities as collateral. CCM invests primarily in healthcare companies in the US, and on an opportunistic basis in the rest of the world.^

Details Hidden

Camber Capital Management seeks to generate capital appreciation without regard to current income. They seek to achieve this objective by investing primarily in publicly-traded common stocks of healthcare companies across a variety of industries including healthcare services and facilities, pharmaceuticals, medical products and devices and biotechnology. Although most of their investments are within the healthcare industry, Camber may occasionally invest in other sectors if more attractive opportunities are identified.Camber employs a fundamental, bottom-up research approach designed to identify high-quality companies whose inherent value is not adequately reflected in a company's market valuation. The firm believes that the excessive focus on short-term returns and near term catalysts within the healthcare space often causes public market prices to greatly overreact to near term news flow. Camber takes on short-term risk in order to capitalize on attractive intermediate- to long-term opportunities. To maximize returns, they may, on occasion, employ the use of leverage.

Recent Transactions
Details Hidden

NuVasive Inc. purchases Safe Passage Neuromonitoring LLC

Details Hidden

NuVasive Inc. purchases Vertera, Inc.

Details Hidden

NuVasive Inc. purchases BNN Holdings Corp. from Stonehenge Partners, Inc., Great Point Partners Private Equity, Prospect Capital Management LP

Insider Transactions
Details Hidden
Transaction Advisors
Legal Advisor

Advised onNuVasive Inc. purchases Ellipse Technologies, Inc. from HBM Partners AG, Biostar Managers LLC, Wexford Capital Private Equity, Medfocus Management Co. LLC

Underwriter

Advised onNuVasive Inc. issued Common Stock

Underwriter

Advised onNuVasive Inc. issued Common Stock

Legal Advisor

Advised onNuVasive Inc. purchases Ellipse Technologies, Inc. from HBM Partners AG, Biostar Managers LLC, Wexford Capital Private Equity, Medfocus Management Co. LLC

Legal Advisor

Advised onNuVasive Inc. purchases Ellipse Technologies, Inc. from HBM Partners AG, Biostar Managers LLC, Wexford Capital Private Equity, Medfocus Management Co. LLC

Escrow Agent

Advised onNuVasive Inc. purchases NuVasive Clinical Services Monitoring, Inc. from Tullis Health Investors, Inc.

Advisors & Consultants
Legal Advisor

Partner at DLA Piper

Legal Advisor

Partner at DLA Piper

Special Advisor

President, Chief Executive Officer & Director at Seaspine Holdings Corp.

Key Stats and Financials As of 2018
Market Capitalization
$3.18B
Total Enterprise Value
$3.08B
Earnings Per Share
$0.24
Revenue
$1.1B
Net Profit
$12.5M
EBITDA
$232M
EBITDAMargin
21.07%
Total Debt
$603M
Total Equity
$835M
Enterprise Value Sales
2.8x
Enterprise Value EBITDAOperating
13.27x
TEVNet Income
246.77x
Debt TEV
0.2x
Three Year Compounded Annual Growth Rate Of Revenue
10.75%
Five Year Compounded Annual Growth Rate Of Revenue
9.96%
Non-Profit Donations & Grants
Political Donations
Investments
Details Hidden

Progentix Orthobiology BV develops CuriOs (TM), a unique suite ofosteoconductive material products for clinical application in bone regenerative surgery. The company was founded by Joost Dick de Bruijn and Clemens A. van Blitterswijk in 2007 and is headquartered in Bilthoven, the Netherlands.

Investors
Details Hidden

Pappas Ventures invests exclusively in the life sciences sector including biotechnology, specialty pharmaceuticals, diagnostics, drug delivery, medical devices and and other related ventures. They typically pursue early- to mid-stage investments. The firm places emphasis on companies with products or technologies at the pre-clinical, Phase 1 or Phase 2 stage of development. They invest across the spectrum of start-up companies to well-established companies.Pappas Ventures focuses on the quality and experience of a potential portfolio company's management team. They look for management teams with a proven track record, the ability to communicate the company's story to a variety of audiences and a deep commitment to creating shareholder value. The firm also seeks companies with a strong proprietary position, a large clearly-defined market and a realistic exit strategy.About one-third of their investments are made in California and about one-third are made in companies on the East Coast of the US including the Research Triangle area of North Carolina. The remaining capital is invested in underserved regions such as Texas, Indiana and Montreal.The firm invest anywhere from a seed deal to a later-stage mezzanine transaction.

Details Hidden

William Blair & Company is a global investment banking and asset management firm. We are committed to building enduring relationships with our clients and providing expertise and solutions to meet their evolving needs. An independent and employee-owned firm, William Blair is based in Chicago, and has office locations in 11 cities, including London, New York, Shanghai, and Zurich.

Details Hidden

Kleiner Perkins Caufield & Byers (KPCB) focuses on investments in the life sciences, biodefense, green technology, information technology and companies with new technologies related to the iPhone and iPod touchpad platform.The firm's information technology investments focus on the consumer, enterprise, semiconductors, security and communications industries. They invest primarily in early-stage ventures that are incubating new companies with proven entrepreneurs and good ideas.KPCB's life sciences investments include medical devices, drugs, vaccines, personalized medicine, diagnostics and healthcare information technology and services. Their pandemic and biodefense investment initiative focuses on investments in companies with innovations in disease surveillance, rapid diagnostics, new vaccine technology, portable and less expensive manufacturing of vaccines and new antiviral drugs.The firm's iFund invests in market-changing ideas and products that extend the iPhone and iPod touch platform. The Fund invests across all sizes and stages. KPCB targets investments in companies that are developing applications, services and components. Their specific areas of interest include: location-based services, social networking, eCommerce (including advertising and payments), communication and entertainment.

Suppliers
Maxigen Biotech, Inc. Biotechnology

Maxigen Biotech, Inc. engages in the development, manufacture, and sale of beauty care products. Its business activities include skin care, and biomedical division. Its Skin Care division face masks, facial cleansers, and body care products. Its Biomedical division offers medical products such as bone graft substitute, ophthalmic viscoelastic, collagen dental graft, collagen wound dressing, and dermal filler injection. The company was founded on December 3, 1998 and is headquartered in Taoyuan, Taiwan.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Stryker Corporation Medical Products & Equipment - Kalamazoo, Michigan

Stryker is one of the world’s leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives.

Medtronic Plc Medical Products & Equipment - Dublin, DU

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by NuVasive Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of NuVasive Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and NuVasive Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/nuvasive-inc-85312
  • https://relationshipscience.com/organization/nuvasive-inc-85312